Spectral AI, Inc.

NASDAQ:MDAI

Medical - Devices

Healthcare
$1.57 +0.28%

+$0.01 today

Market cap
$50.53M
Beta
1.15
P/E (TTM)
-4.0
EPS (TTM)
-$0.45
52W Low $1.18High $3.21

Volume 0.07M

Average 1.00M

MDAI Cost of Revenue

Direct costs of producing the goods and services sold, such as materials, manufacturing, and service delivery.

Spectral AI, Inc.NASDAQ: MDAI

Cost of Revenue · Q1 FY2026 · quarter ended Mar 2026

Cost of revenue declines year over year

Q1 FY2026 cost of revenue of $1.96M fell 44.5% year over year, behind the -44.0% change in trailing-twelve-month cost of revenue. Sequentially, it fell 15.3% from the prior quarter. Over 3 fiscal years it compounded at -9.6% a year.

Context

  • Cost of revenue amounted to 54.6% of revenue in FY2025, down 0.5 pp from a year earlier.
  • Cost of revenue increased in 1 of the last 3 fiscal years.

What to watch

Whether quarterly growth recovers from -44.5% toward the trailing-twelve-month pace of -44.0%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
$1.96M-15.3% QoQ
Last fiscal yearDec 2025
$10.73M-34.2% YoY
LTMMar 2026
$9.23M-44.0% YoY
Cost of Revenue past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-44.5%——
1 year-34.2%——
3-year CAGR-9.6%——
5-year CAGR——
10-year CAGR——

Cost of Revenue history

USD · from the income statement

Latest · FY2025
10.73M USD
Year-over-year change
-34.2%
4-year CAGR
+7.0%

Cost of Revenue vs competitors

How MDAI compares with its peers on the latest reported figures

  • MDAI's LTM Mar 2026 cost of revenue of $9.23M is the 4th highest of the 9 companies compared; the peer median is $5.23M.
  • Its year-over-year change of -44.0% is the lowest of 6, against a peer median of +9.4%.
  • Cost of revenue amounts to 55.3% of revenue for MDAI, versus a peer median of 12.8%.
MDAI Competitors Peer median
Cost of Revenue for MDAI and competitors
Company Period LTM YoY 3-year CAGR% of revenue
IPSCCentury Therapeutics, Inc.LTM Mar 2026$29.86M ———
TELATELA Bio, Inc.LTM Jun 2026$25.72M +4.4%+21.7%32.2%
SRTSSensus Healthcare, Inc.LTM Mar 2026$14.03M -19.2%+1.6%62.3%
MDAISpectral AI, Inc.LTM Mar 2026$9.23M -44.0%-9.6%55.3%
KPTIKaryopharm Therapeutics Inc.LTM Mar 2026$6.01M +9.4%+4.5%4.0%
ECORelectroCore, Inc.LTM Mar 2026$4.45M +13.8%+38.0%12.8%
COEPCoeptis Therapeutics, Inc.LTM Mar 2026$180.63K +300.0%—12.8%
EQEquillium, Inc.LTM Mar 2026$79K ———
TELOTelomir Pharmaceuticals, Inc. Common StockLTM Mar 2026$0 ———
Peer median (excluding MDAI) $5.23M+9.4%+13.1%12.8%

Competitors are the stored peer set for MDAI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue15.24M25.37M18.06M29.58M19.65M
Cost of Revenue8.19M14.53M10.18M16.31M10.73M
Gross Profit7.05M10.84M7.88M13.27M8.93M
Gross Margin46.3%42.7%43.6%44.9%45.4%
Research & Development00029.58M19.65M
Selling, General & Admin11.23M13.48M20.86M19.86M17.53M
Operating Expenses11.23M13.48M20.86M19.86M17.53M
Depreciation & Amortization1K568K722K588K635K
EBITDA(4.09M)(2.24M)(20.12M)(11.49M)(5.42M)
EBITDA Margin-26.8%-8.8%-111.4%-38.8%-27.6%
Operating Income(4.18M)(2.65M)(12.98M)(6.58M)(8.6M)
Operating Margin-27.4%-10.4%-71.9%-22.3%-43.8%
Interest Income021K172K14K(886K)
Interest Expense0002.97M1.51M
Other Income / Expenses93K(159K)(7.86M)(8.46M)1.04M
Income Before Tax(4.09M)(2.81M)(20.84M)(15.04M)(7.56M)
Pre-Tax Margin-26.8%-11.1%-115.4%-50.9%-38.5%
Income Tax Expense(98K)106K11K271K11K
Net Income(3.99M)(2.91M)(20.85M)(15.32M)(7.57M)
Net Margin-26.2%-11.5%-115.5%-51.8%-38.5%
EPS (Basic)(0.33)(0.16)(1.48)(0.85)(0.29)
EPS (Diluted)(0.33)(0.16)(1.48)(0.85)(0.29)
Weighted Avg Shares17.88M17.88M14.09M17.93M26.52M
Weighted Avg Shares (Diluted)17.88M17.88M14.09M17.93M26.52M

Spectral AI, Inc.

NASDAQ:MDAI

Intrinsic Alpha fair value

Locked

Current Price

$1.57

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.